Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis

Detalles Bibliográficos
Autores principales: Bewersdorf, Jan Philipp, Giri, Smith, Wang, Rong, Williams, Robert T., Tallman, Martin S., Zeidan, Amer M., Stahl, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604631/
https://www.ncbi.nlm.nih.gov/pubmed/33131256
http://dx.doi.org/10.3324/haematol.2019.242826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604631/
https://www.ncbi.nlm.nih.gov/pubmed/33131256
http://dx.doi.org/10.3324/haematol.2019.242826

Ejemplares similares